Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5.

Journal Article (Journal Article;Review)

The prevalence of cardiovascular disease (CVD) in pregnancy, both diagnosed and previously unknown, is rising, and CVD is a leading cause of maternal morbidity and mortality. Historically, women of child-bearing potential have been underrepresented in research, leading to lasting knowledge gaps in the cardiovascular care of pregnant and lactating women. Despite these limitations, clinicians should be familiar with the safety of frequently used diagnostic and therapeutic interventions to adequately care for this at-risk population. This review, the fourth of a 5-part series, provides evidence-based recommendations regarding the use of common cardiovascular diagnostic tests and medications in pregnant and lactating women.

Full Text

Duke Authors

Cited Authors

  • Bello, NA; Bairey Merz, CN; Brown, H; Davis, MB; Dickert, NW; El Hajj, SC; Giullian, C; Quesada, O; Park, K; Sanghani, RM; Shaw, L; Volgman, AS; Wenger, NK; Williams, D; Pepine, CJ; Lindley, KJ; American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group,

Published Date

  • April 13, 2021

Published In

Volume / Issue

  • 77 / 14

Start / End Page

  • 1813 - 1822

PubMed ID

  • 33832607

Pubmed Central ID

  • PMC8221542

Electronic International Standard Serial Number (EISSN)

  • 1558-3597

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2021.01.056


  • eng

Conference Location

  • United States